Primary Peritoneal Carcinoma Not Yet Recruiting Phase 2 Trials for Nivolumab (DB09035)

IndicationStatusPhase
DBCOND0028874 (Primary Peritoneal Carcinoma)Not Yet Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs